MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group.
Saved in:
| Title: | MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group. |
|---|---|
| Authors: | Öz G; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA. gulin@cmrr.umn.edu., Cocozza S; Department of Advanced Biomedical Sciences, University of Naples 'Federico II', Naples, Italy., Rezende TJR; Department of Neurology, School of Medical Sciences, University of Campinas, Campinas, Brazil., Henry PG; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA., Faber J; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Center for Neurology, Department of Parkinson's Disease, Sleep and Movement Disorders, University Hospital Bonn, Bonn, Germany.; Department of Neuroradiology, University Hospital Bonn, Bonn, Germany., Harding IH; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. |
| Corporate Authors: | Ataxia Global Initiative Working Group on MRI Biomarkers |
| Source: | Nature reviews. Neurology [Nat Rev Neurol] 2026 Jul; Vol. 22 (7), pp. 439-456. Date of Electronic Publication: 2026 Jun 03. |
| Publication Type: | Journal Article; Review; Consensus Statement |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500072 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4766 (Electronic) Linking ISSN: 17594758 NLM ISO Abbreviation: Nat Rev Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
